Inhibitors of tumor necrosis factor in rheumatoid arthritis: Will that dog hunt?

被引：0
|
作者：
Kavanaugh, A
Cohen, S
Cush, J
机构：
来源：
JOURNAL OF RHEUMATOLOGY | 1998年 / 25卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2049 / 2053
页数：5
相关论文
共 50 条
  • [31] Is there a pharmacoeconomic argument supporting the use of tumor necrosis factor inhibitors in early rheumatoid arthritis?
    Kavanaugh, Arthur
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (07): : 346 - 347
  • [32] Ischemic Colitis During Treatment with Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis
    Salk, Allison
    Stobaugh, Derrick
    Deepak, Parakkal
    Ehrenpreis, Eli
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S208 - S208
  • [33] Persistence and Dose Escalation of Tumor Necrosis Factor Inhibitors in US Veterans with Rheumatoid Arthritis
    Cannon, Grant W.
    DuVall, Scott L.
    Haroldsen, Candace L.
    Caplan, Liron
    Curtis, Jeffrey R.
    Michaud, Kaleb
    Mikuls, Ted R.
    Reimold, Andreas
    Collier, David H.
    Harrison, David J.
    Joseph, George J.
    Sauer, Brian C.
    JOURNAL OF RHEUMATOLOGY, 2014, 41 (10) : 1935 - 1943
  • [34] Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients with Rheumatoid Arthritis
    Kim, Seoyoung C.
    Solomon, Daniel H.
    Rogers, James R.
    Gale, Sara
    Klearman, Micki
    Sarsour, Khaled
    Schneeweiss, Sebastian
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [35] The kynurenine pathway in patients with rheumatoid arthritis during tumor necrosis factor α inhibitors treatment
    Witoszynska-Sobkowiak, Joanna
    Sikorska, Dorota
    Niklas, Karolina
    Zychowska, Iwona
    Rutkowski, Rafal
    Samborski, Wlodzimierz
    REUMATOLOGIA, 2024, 62 (04): : 220 - 225
  • [36] Tumor Necrosis Factor Inhibitors and the Risk of Cancer among Older Americans with Rheumatoid Arthritis
    D'Arcy, Monica E.
    Beachler, Daniel C.
    Pfeiffer, Ruth M.
    Curtis, Jeffrey R.
    Mariette, Xavier
    Seror, Raphaele
    Mahale, Parag
    Rivera, Donna R.
    Yanik, Elizabeth L.
    Engels, Eric A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2021, 30 (11) : 2059 - 2067
  • [37] LABORATORY SAFETY OF ADALIMUMAB AND OTHER TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF RHEUMATOID ARTHRITIS
    Pappas, D. A.
    Shaw, J. W.
    Chang, H.
    Cifaldi, M. A.
    Reed, G. W.
    Garg, V.
    Lacerda, A. P.
    Mozaffarian, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 931 - 931
  • [38] Monoclonal antibodies in rheumatoid arthritis: comparative effectiveness of tocilizumab with tumor necrosis factor inhibitors
    Tanaka, Toshio
    Hishitani, Yoshihiro
    Ogata, Atsushi
    BIOLOGICS-TARGETS & THERAPY, 2014, 8 : 141 - 153
  • [39] Neutrophil biomarkers predict response to therapy with tumor necrosis factor inhibitors in rheumatoid arthritis
    Wright, Helen L.
    Cox, Trevor
    Moots, Robert J.
    Edwards, Steven W.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2017, 101 (03) : 785 - 795
  • [40] Comparative Persistence of Methotrexate and Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    George, Michael D.
    Baker, Joshua F.
    Ogdie, Alexis
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (06) : 826 - 834
12345